Brand Name
Haldol
Broad Category
Antipsychotic / Antiemetic
Pharmacological Class
First gen antipsychotic / Butyrophenone
MOA
Blocks D2 receptors in the basal ganglia and limbic portions of the forebrain
Indications / Clinical Uses
PONV
Psychiatric illness (psychoses and Schizophrenia)
Agitation
Antiemetic dosing
1-2 mg IV
Onset
3-10 mins
Duration
4-8 hours
CV effects
QT prolongation
CNS effects
EPS
- tardive dyskinesia
Endocrine effects
Hyperprolactinemia
Sexual Dysfunction
Other Concerns?
Neuroleptic Malignant Syndrome
Metabolism
Extensive Hepatic
- CYP3A4
- CYP2D6
Elimination
Renal
Biliary
Vd considerations
Very large
- highly lipophillic
- extensive tissue distribution
- crosses BBB
Protein binding
High (90-92%)
Clearance Considerations
Reduced clearance with
- Hepatic impairment
- CYP enzyme inhibition
Absolute Contraindications
Parkinson’s
Hypersensitivity
Severe CNS depression / sedation
QT prolongation
Precautions
History of NMS
Hepatic impairment
Elderly dementia pts (increased mortality risk)